Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc.
Your view on HRMY
Overview
What the company does, where it operates, and who runs it.
About Harmony Biosciences Holdings, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Jeffrey M. Dayno
- Headquarters
- 630 West Germantown Pike, Plymouth Meeting, PA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Jeffrey M. Dayno
- Headquarters
- 630 West Germantown Pike, Plymouth Meeting, PA, US
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.